Skip to nav Skip to content

News Releases and Statements

Facebook Twitter LinkedIn Email

IDSA Foundation, Johnson & Johnson Innovation – JLABS to Host 2021 IDea Incubator Competition

IDSA Foundation, in collaboration with Johnson & Johnson Innovation – JLABS will host the 2021 IDea Incubator, the premier showcase of technology in the field of infectious diseases and a pitch-style competition that drives innovations across various disciplines with the potential to improve the infectious diseases specialty and patient care.

G7 Nations Commit to Combating AMR

In separate United Kingdom meetings June 3-5, G7 ministers of health and finance committed their nations to confronting the growing threat of antimicrobial resistance, with meaningful and concrete actions. The concluding documents from the ministers’ meetings directly address priorities promoted by the Infectious Diseases Society of America. With commitments to foster new antibiotic development through international and cross-sectoral collaboration

President’s Budget Proposal Takes Important Steps Toward Renewed Global Health Leadership, Leaves Challenging Gaps

With significant increases and meaningful investments in U.S. Centers for Disease Control and State Department global health programs, President Biden’s proposed budget for the coming fiscal year offers the promise of renewing our country’s role as a leader of infectious disease responses that can detect, prevent and contain public health threats where they emerge.

IDSA and HIVMA Respond to New CDC Masking Guidance for Fully Vaccinated People

The U.S. Centers for Disease Control and Prevention recommendations that fully immunized people can resume most daily activities without masks or concern for physical distancing, except where required by laws and policies, reflect the remarkable protective benefit of COVID-19 vaccines.

Representatives Call on House Appropriators to Raise Resources to Combat AMR

More than 60 Congressional representatives from both sides of the aisle have called on House appropriators to significantly increase federal resources in the year ahead to tackle the growing crisis of infections that do not respond to available treatments.

COVID-19 Crisis Continues to Call for More International Collaboration and Investment

The Biden Administration’s pledge of medical aid for India to combat the country’s surge of COVID-19 shows an important commitment to tackling the pandemic as a shared crisis. We commend the Administration for taking this step and for its plans to share up to 60 million doses of the AstraZeneca vaccine.

Response from Infectious Diseases Society of America President Barbara D. Alexander, MD, MHS, FIDSA to the Suspension of the Johnson & Johnson COVID-19 Vaccine

“Today’s announcement by FDA and CDC to temporarily pause the administration of the Johnson & Johnson COVID-19 vaccine is an indication that our safety monitoring system is working." Read More.

President Biden’s Proposed Budget Plan Lays a Foundation for Strengthened and Expanded Health, Security and Equity

President Biden’s first proposed budget plan released today sends an encouraging message of intent to strengthen our nation’s health infrastructure, renew our standing as global leaders against infectious diseases and make our powerful resources equitably accessible to all Americans.

HELP Act Will Bolster HIV Workforce and Bring Nation Much Closer To Ending HIV Epidemic

The HIV Medicine Association and the Infectious Diseases Society of America applaud the introduction of legislation on Friday by Rep. Lisa Blunt Rochester (D-AL) to address the critical shortage of clinicians and dentists caring for people with HIV

IDSA Launches Print Opt-Out for The Journal of Infectious Diseases

In response to member feedback, IDSA has launched a print opt-out option for all members that receive biweekly issues of The Journal of Infectious Diseases in hard copy. Members that prefer not to receive JID in print may now receive their regular issues in electronic-only format.

World TB Day 2021: As We Make Progress Against COVID-19, We Must Not Lose More Ground Against Tuberculosis

While COVID-19 has taken the place of tuberculosis as the world’s leading infectious disease killer, on this World TB Day the ancient disease remains our oldest and most neglected epidemic despite being preventable and curable.

Cross-Sector Coalition Calls for Significantly Increased Investments to Combat AMR

A coalition of organizations representing clinicians, scientists, patients, public health professionals and animal agriculture experts as well as members of the pharmaceutical and diagnostics industries are asking congressional leaders to significantly increase U.S. investments

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.